- Telehealth Visits
- Insurances Accepted
Mari-Paule Thiet, MD
Maternal-Fetal MedicineDirector, Maternal-Fetal Medicine- Telehealth Visits
- Insurances Accepted
Mari-Paule Thiet, MD
Maternal-Fetal MedicineDirector, Maternal-Fetal Medicine- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Mari-Paule Thiet is a perinatologist, an obstetrician who specializes in the prenatal period, particularly for high-risk or complicated pregnancies. She directs maternal-fetal medicine at UCSF.
Thiet earned her medical degree from the University of Texas Southwestern Medical School. She completed her residency in obstetrics and gynecology at Parkland Health & Hospital System. She completed a fellowship in maternal and fetal medicine at the George Washington University Hospital.
Education
Board Certification
- Maternal-Fetal Medicine, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Maternal and Fetal Medicine, George Washington University Hospital
Residency
- Obstetrics & Gynecology, Parkland Health & Hospital System
Internship
- Obstetrics & Gynecology, Parkland Health & Hospital System
School
- MD, University of Texas Southwestern Medical School
Academic Title
- Clinical Professor
Care Keywords
Services
- Maternal-Fetal Medicine
Conditions
- Pregnancy
- High-Risk Pregnancy
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22927%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22927%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.